IL-2, IL-6 and chitinase 3-like 2 might predict early relapse activity in multiple sclerosis von Petrzalka, Marko, Meluzínová, Eva, Libertínová, Jana, Mojzisová, Hana, Hanzalová, Jitka, Rocková, Petra, Elisák, Martin, Kmetonyová, Silvia, Sanda, Jan, Sobek, Ondrej, Marusic, Petr

Volltext

Spatial navigation in early multiple sclerosis: a neglected cognitive marker of the disease? von Němá, Eva, Kalina, Adam, Nikolai, Tomáš, Vyhnálek, Martin, Meluzínová, Eva, Laczó, Jan

Volltext

Correction to: Spatial navigation in early multiple sclerosis: a neglected cognitive marker of the disease? von Němá, Eva, Kalina, Adam, Nikolai, Tomáš, Vyhnálek, Martin, Meluzínová, Eva, Laczó, Jan

Volltext

Cognitive impairment and structural brain changes in patients with clinically isolated syndrome at high risk for multiple sclerosis von Hynčicová, Eva, Vyhnálek, Martin, Kalina, Adam, Martinkovič, Lukáš, Nikolai, Tomáš, Lisý, Jiří, Hort, Jakub, Meluzínová, Eva, Laczó, Jan

Volltext

Analysis of the Group of Pediatric Patients With Relapsing-Remitting Multiple Sclerosis: Data From the Czech National Registry von Vališ, Martin, Pavelek, Zbyšek, Novotný, Michal, Klímová, Blanka, Šarláková, Jana, Halúsková, Simona, Peterka, Marek, Štětkárová, Ivana, Štourač, Pavel, Mareš, Jan, Hradílek, Pavel, Ampapa, Radek, Vachová, Marta, Recmanová, Eva, Meluzínová, Eva

Volltext

Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study von Kappos, Ludwig, Prof, Gold, Ralf, Prof, Miller, David H, Prof, MacManus, David G, MSc, Havrdova, Eva, MD, Limmroth, Volker, MD, Polman, Chris H, Prof, Schmierer, Klaus, PhD, Yousry, Tarek A, MD, Yang, Minhua, MS, Eraksoy, Mefkûre, Prof, Meluzinova, Eva, MD, Rektor, Ivan, MD, Dawson, Katherine T, MD, Sandrock, Alfred W, MD, O'Neill, Gilmore N, MB

Volltext

Health-related quality of life, neuropsychiatric symptoms and structural brain changes in clinically isolated syndrome von Hyncicova, Eva, Kalina, Adam, Vyhnalek, Martin, Nikolai, Tomas, Martinkovic, Lukas, Lisy, Jiri, Hort, Jakub, Meluzinova, Eva, Laczó, Jan

Volltext

Elevated D-dimer as an immediate response to alemtuzumab treatment von Libertinova, Jana, Meluzinova, Eva, Nema, Eva, Rockova, Petra, Elisak, Martin, Petrzalka, Marko, Mojzisova, Hana, Hammer, Jiri, Tomek, Ales, Marusic, Petr

Volltext

Prevalence of neurodegenerative/demyelinating disorders in patients with achalasia von Jerie, Martin, Vackova, Zuzana, Vojtech, Zdenek, Mares, Jan, Meluzinova, Eva, Krajciova, Jana, Vymazal, Josef, Cerna, Hana, Martinek, Jan

Volltext

Myxovirus Resistance Protein A mRNA Expression Kinetics in Multiple Sclerosis Patients Treated with IFNβ von Libertinova, Jana, Meluzinova, Eva, Tomek, Ales, Horakova, Dana, Kovarova, Ivana, Matoska, Vaclav, Kumstyrova, Simona, Zajac, Miroslav, Hyncicova, Eva, Liskova, Petra, Houzvickova, Eva, Martinkovic, Lukas, Bojar, Martin, Havrdova, Eva, Marusic, Petr

Volltext

IL-2, IL-6 and chitinase 3-like 2 might predict early relapse activity in multiple sclerosis von Marko Petržalka, Eva Meluzínová, Jana Libertínová, Hana Mojžišová, Jitka Hanzalová, Petra Ročková, Martin Elišák, Silvia Kmetonyová, Jan Šanda, Ondřej Sobek, Petr Marusič

Volltext

Management of psoriasis vulgaris and multiple sclerosis with fumaric acid von Gkalpakiotis, Spyridon, MD, PhD, Arenberger, Petr, MD, PhD, DSc, Prof, Gkalpakioti, Petra, MD, Meluzinova, Eva, MD, Chandran, Devika, MD, Arenbergerova, Monika, MD, PhD

Volltext

Safety and efficacy of tolebrutinib, an oral brain-penetrant BTK inhibitor, in relapsing multiple sclerosis: a phase 2b, randomised, double-blind, placebo-controlled trial von Reich, Daniel S, Arnold, Douglas L, Vermersch, Patrick, Bar-Or, Amit, Fox, Robert J, Matta, Andre, Turner, Timothy, Wallström, Erik, Zhang, Xinyan, Mareš, Miroslav, Khabirov, Farit A, Traboulsee, Anthony, Grand'Maison, Francois, Jacques, Francois, Traboulsee, Anthony, Tyblova, Michaela, Meluzinova, Eva, Ampapa, Radek, Valis, Martin, Hradilke, Pavel, Mareš, Miroslav, Stourac, Pavel, Gross-Paju, Katrin, Laplaud, David, Mathey, Guillaume, Uitdehaag, Bernard, Evdoshenkoo, Evgeny, Popova, Ekaterina, Zakharova, Maria, Totolyan, Natalia, Litvinenko, Igor, Khabirov, Farit, Sivertseva, Stella, Hancinova, Viera, Kantorova, Ema, Gines, Maria Luisa Martinez, Montalban, Xavier, Maduano, Sara Eichau, Meca-Lallana, Jose, Ramió-Torrentà, Lluís, Nehrych, Tetyanna, Pashkovskyy, Valeriy, Moskovko, Sergii, Kalbus, Oleksandr, Khavunka, Marta, Pryshchepa, Volodymyr, Goloborodko, Alla, Wynn, Daniel, Honeycutt, William, Wray, Sibyl, Steingo, Brian, LaGanke, Christopher, Huang, Deren, Hemphill, John Michael, Goldstick, Lawrence, Robertson, Derrick

Volltext

Switching from natalizumab to fingolimod: A randomized, placebo-controlled study in RRMS von Kappos, Ludwig, Radue, Ernst-Wilhelm, Comi, Giancarlo, Montalban, Xavier, Butzkueven, Helmut, Wiendl, Heinz, Giovannoni, Gavin, Hartung, Hans-Peter, Derfuss, Tobias, Naegelin, Yvonne, Sprenger, Till, Mueller-Lenke, Nicole, Griffiths, Sarah, von Rosenstiel, Philipp, Gottschalk, Rebecca, Zhang, Ying, Dahlke, Frank, Tomic, Davorka

Volltext

Sa1659 - An Increased Prevalence of Neurodegenerative/Demyelinating Processes in Patients with Esophageal Achalasia and a Prospective Study von Svecova, Hana, Jerie, Martin, Meluzinova, Eva, Kautznerova, Dana, Spicak, Julius, Krajciova, Jana, Vackova, Zuzana, Martinek, Jan

Volltext

An Increased Prevalence of Neurodegenerative/Demyelinating Processes in Patients with Esophageal Achalasia and a Prospective Study von Svecova, Hana, Jerie, Martin, Meluzinova, Eva, Kautznerova, Dana, Spicak, Julius, Krajciova, Jana, Vackova, Zuzana, Martinek, Jan

Volltext

Is pregnancy in MS patients safe and what is its impact on MS course? Real World evidence of 1533 pregnancies in Czech Republic von Hradilek, Pavel, Meluzinova, Eva, Zapletalova, Olga, Hanulikova, Petra, Horakova, Dana, Woznicova, Ivana, Pavliska, Lubomir, Stetkarova, Ivana, Valis, Martin, Stourac, Pavel, Adamkova, Jana, Ampapa, Radek, Vachova, Marta, Mares, Jan

Volltext

Understanding the positive benefit:risk profile of alemtuzumab in relapsing multiple sclerosis: perspectives from the Alemtuzumab Clinical Development Program von Havrdova, Eva, Cohen, Jeffrey A, Horakova, Dana, Kovarova, Ivana, Meluzinova, Eva

Volltext

Myxovirus Resistance Protein A mRNA Expression Kinetics in Multiple Sclerosis Patients Treated with IFN[beta] von Libertinova, Jana, Meluzinova, Eva, Tomek, Ales, Horakova, Dana, Kovarova, Ivana, Matoska, Vaclav, Kumstyrova, Simona, Zajac, Miroslav, Hyncicova, Eva, Liskova, Petra, Houzvickova, Eva, Martinkovic, Lukas, Bojar, Martin, Havrdova, Eva, Marusic, Petr

Volltext

Effect of BG-12 on contrast-enhanced lesions in patients with relapsing– remitting multiple sclerosis: subgroup analyses from the phase 2b study von Kappos, Ludwig, Gold, Ralf, Miller, David H, MacManus, David G, Havrdova, Eva, Limmroth, Volker, Polman, Chris H, Schmierer, Klaus, Yousry, Tarek A, Eraksoy, Mefkure, Meluzinova, Eva, Dufek, Michal, Yang, Minhua, Dawson, Kate, O’Neill, Gilmore N

Volltext